Brief: Sequana Medical Reduces Forecast Cash Need For 2024 To Additional EUR 13.0 Mln
Feb 8 (Reuters) - Sequana Medical NV SEQUA.BR :
* FOCUS ON OBTAINING ALFAPUMP PMA APPROVAL REDUCES FORECAST
CASH
NEED FOR 2024 TO ADDITIONAL EUR 13.0 MILLION
* ANNOUNCE TODAY GRANTING OF AN UNSECURED SUBORDINATED
CONVERTIBLE
LOAN OF EUR 3.0 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nGNE9vq6t9
Further company coverage: SEQUA.BR
(Gdansk Newsroom)
((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))
Recent news on Sequana Medical NV
See all newsAdvisory: Alert wrongly tagged to Decision Diagnostics withdrawn
Brief: Sequana Medical Board Resolves To File For Bankruptcy With Ghent Enterprise Court
Brief: Sequana Medical H1 Revenue EUR 106 Thousand
Brief: Sequana Medical H1 Revenue EUR 106 Thousand
Brief: Sequana Medical FY EBIT EUR -28.862 Million